Tradestie Institutional Equity Comparison Engine

ISPC vs MXCT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ISPC trades at N/M Forward P/E with -1455.3% operating margin (+128.9% YoY revenue) versus MXCT at N/M Forward P/E and -85.5% operating margin (+48.7% YoY). In options structure, ISPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ISPC N/M vs MXCT N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -1455.3% vs -85.5% ยท YoY +128.9% vs +48.7%
Momentum & Technical Winner MXCT
1Y -10.0% vs -19.4% ยท 52W Pos 5% vs 63%
Options & Structure Winner MXCT
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ISPC NASDAQ
iSpecimen Inc. Common Stock
Services-Commercial Physical & Biological Research
$0.46
-13.58% 1D
Market Cap $3.1M
1M Return -45.2%
1Y Return -10.0%
Forward P/E N/M
Unified AI Score
41.6 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ISPC -10.0% MXCT -19.41% Spread: +9.41 pp (ISPC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ISPC Revenue MXCT Revenue ISPC Op. Margin MXCT Op. Margin Margin Edge
FY2019 N/A $10M N/A -93.7% MXCT
FY2020 $10M $20M -29.4% -71.6% ISPC
FY2021 $10M $20M -53.2% -84.3% ISPC
FY2022 $10M $30M -97.9% -95.2% MXCT
FY2023 $10M $20M -112.5% -247.7% ISPC
FY2024 $10M $20M -137.0% -230.5% ISPC
FY2025 $0M $20M -465.4% -247.6% MXCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ISPC (3) vs MXCT (4)
Institutional Metric ISPC MXCT Criterion Row Winner
Market Capitalization Scale $3.1M $132.2M Larger Scale MXCT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +128.9% +48.7% Higher Growth ISPC
Operating Margin (TTM) Profitability -1455.3% -85.5% Higher Margin MXCT
Net Profit Margin Profitability 0.0% -81.4% Higher Margin ISPC
Return on Equity (ROE) Capital Efficiency -303.9% -16.9% Higher ROE MXCT
52-Week Range Position Momentum 5% ($0โ€“$7) 63% ($1โ€“$2) Stronger Trend MXCT
Beta / 30D Volatility Risk Regime -10.07ฮฒ ยท 74% Vol 1.19ฮฒ ยท 96% Vol Lower Realized Risk ISPC
Unified Institutional Score Composite Signal 41.6 / 100 (SELL) 41.7 / 100 (SELL) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ISPC vs MXCT Buy Guide
ISPC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ISPC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ISPC nor MXCT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.